Moreover, another three potential drugs, phloretin, cucurbitacin B, and bimosiamose, which are the inhibitors of AQP9, STAT3, and SELL, respectively, have been reported to improve neurologic deficits after rat cerebral ischemia by reducing oxidative stress (70–72). The gene discussed is SELL; the disease is Cerebral ischemia.